Post-Stroke Osteopathy
1 other identifier
observational
127
1 country
1
Brief Summary
The sudden biomechanical inactivation, direct neuro-humoral effects and sustained systemic stress reaction, which commonly occur after stroke or TIA, all may be of relevance in triggering alterations in bone metabolism and remodelling of bone microstructure. The objectives of this observational pilot study are to characterize falls and fractures and their circumstances (sex and age specific incidence, time course, risk conditions, localization) in ischemic stroke patients, study changes in the bone microstructure after ischemic stroke supported by high-resolution peripheral quantitative Computer Tomography, unravel a molecular mechanisms underlying the increased fracture risk (focus on Wnt-signaling and ß-adrenergic projection), establish risk factors to estimate the risk of falls based on information from gait analysis as well as construct deep learning algorithms to identify bone microstructure parameters for predicting fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2021
CompletedFirst Submitted
Initial submission to the registry
April 7, 2021
CompletedFirst Posted
Study publicly available on registry
April 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedJune 22, 2023
June 1, 2023
2.2 years
April 7, 2021
June 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with and without fractures
12 months
Other Outcomes (4)
Changes in imaging bone structure between the baseline and follow-up in all extremities as measured by quantitative CT imaging
12 months
Number and circumstances (housing situation, concomitant medication, level of immobility,...) of falls between baseline and one-year follow-up
12 months
Change in blood bone biomarkers (as mentioned before) between baseline and follow-up
12 months
- +1 more other outcomes
Eligibility Criteria
As a sub-study of the STROKE-CARD Registry Study the source population will be all patients treated at the Department of Neurology Innsbruck (Austria) for stroke and included in the STROKE-CARD Registry Study. The target study population for the Post-Stroke Osteopathy Study will be all patients included in the STROKE-CARD Registry Study (clinicaltrials.gov ID NCT04582825).
You may qualify if:
- Modified Rankin Scale (mRS) \< 5
- Provision of signed and dated informed consent form
- Willingness to comply with all study procedures and ability to participate in the study over the complete study duration
You may not qualify if:
- Persistent motor deficit before the onset event
- Not able to walk without walking aid or not able to put the full bodyweight on either leg before the onset event
- Medical history of stroke
- Premedication with Corticosteroids for more than 6 Weeks or Pioglitazone or Bisphosphonate within the last 12 months
- Limb amputation
- BMI \< 18,5 kg/m2 or \> 35 kg/m2
- Present or previous fracture in the distal Radius or Tibia interfering with HR-pQCT
- Movement disorder interfering with HR-pQCT imaging
- Women of childbearing potential
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VASCage GmbHlead
- Medical University Innsbruckcollaborator
Study Sites (1)
Medical University of Innsbruck, Department of Neurology
Innsbruck, 6020, Austria
Related Publications (8)
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
PMID: 30496103BACKGROUNDYuan ZC, Mo H, Guan J, He JL, Wu ZJ. Risk of hip fracture following stroke, a meta-analysis of 13 cohort studies. Osteoporos Int. 2016 Sep;27(9):2673-2679. doi: 10.1007/s00198-016-3603-x. Epub 2016 Apr 22.
PMID: 27101998BACKGROUNDRamnemark A, Nyberg L, Borssen B, Olsson T, Gustafson Y. Fractures after stroke. Osteoporos Int. 1998;8(1):92-5. doi: 10.1007/s001980050053.
PMID: 9692083BACKGROUNDRamnemark A, Nilsson M, Borssen B, Gustafson Y. Stroke, a major and increasing risk factor for femoral neck fracture. Stroke. 2000 Jul;31(7):1572-7. doi: 10.1161/01.str.31.7.1572.
PMID: 10884456BACKGROUNDRamnemark A, Nyberg L, Lorentzon R, Olsson T, Gustafson Y. Hemiosteoporosis after severe stroke, independent of changes in body composition and weight. Stroke. 1999 Apr;30(4):755-60. doi: 10.1161/01.str.30.4.755.
PMID: 10187874BACKGROUNDCarda S, Cisari C, Invernizzi M, Bevilacqua M. Osteoporosis after stroke: a review of the causes and potential treatments. Cerebrovasc Dis. 2009;28(2):191-200. doi: 10.1159/000226578. Epub 2009 Jun 30.
PMID: 19571530BACKGROUNDPoole KE, Vedi S, Debiram I, Rose C, Power J, Loveridge N, Warburton EA, Reeve J, Compston J. Bone structure and remodelling in stroke patients: early effects of zoledronate. Bone. 2009 Apr;44(4):629-33. doi: 10.1016/j.bone.2008.11.017. Epub 2008 Dec 11.
PMID: 19121416BACKGROUNDRamnemark A, Nyberg L, Lorentzon R, Englund U, Gustafson Y. Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporos Int. 1999;9(3):269-75. doi: 10.1007/s001980050147.
PMID: 10450417BACKGROUND
Related Links
Biospecimen
CTX1 und CTX 2, Osteocalcin, TRAP5b, Bone Alkaline Phosphatase, Sclerostin, Periostin, RANKL-OPG-Ratio
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Knoflach, Assoz.Prof. Priv.-Doz. Dr.
Medical University of Innsbruck, Department of Neurology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2021
First Posted
April 14, 2021
Study Start
March 31, 2021
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
June 22, 2023
Record last verified: 2023-06